Compartir
Titolo
Surveillance of strongyloidiasis in Spanish in-patients (1998–2014)
Autor(es)
Soggetto
Strongyloidiasis
Estrongiloidiasis
Fecha de publicación
2017-12-28
Editore
Public Library of Science.
Citación
Belhassen-García M, Alonso-Sardón M, Martinez-Perez A, Soler C, Carranza-Rodriguez C, Pérez-Arellano JL, et al. (2017) Surveillance of strongyloidiasis in Spanish in-patients (1998–2014). PLoS ONE 12(12):e0189449. https://doi.org/10.1371/journal.pone.0189449
Resumen
[EN]Background:
Strongyloides stercoralis is a parasite that causes strongyloidiasis, a neglected tropical disease.
S. stercoralis is a soil-transmitted helminth that is widely distributed in tropical and
subtropical regions of the world. Strongyloidiasis can occur without any symptoms or as a
chronic infection characterized by mild, unspecific symptoms such as pruritus, abdominal
pain or discomfort; respiratory impairment also may manifest as a potentially fatal hyperinfection
or disseminated infection. Most studies on strongyloidiasis in Spain have been
related to chronic forms in immigrants or travellers from endemic zones and have mainly
analysed out-patient populations. Studies of the impact of strongyloidiasis cases admitted to
hospitals in Spain are lacking. Therefore, the aim of this study was to analyse the impact of
strongyloidiasis in hospital care in Spain.
Methodology:
We designed a retrospective descriptive study using the Minimum Basic Data Set (MBDS,
CMBD in Spanish) for inpatients with ICD-9: 127.2 (strongyloidiasis) diagnoses admitted to
hospitals in the Spanish National Health System between 1998 and 2014.
Principal findings:
A total of 507 hospitalizations with diagnosis of strongyloidiasis were recorded, 324 cases
(63.9%) were males. The mean (±SD) age was 42.1±20.1 years. The impact of strongyloidiasis
on the total population of Spain was 0.06 cases per 105 person-years, and the infection
burden increased progressively over time (from 0.01 cases per 105 person-years in 1999 to
0.10 cases per 105 person-years in 2014). 40 cases (7.9%) died. The total cost was approximately
€8,681,062.3, and the mean cost per patient was €17,122.4±97,968.8.
Conclusions:
Our data suggest that strongyloidiasis is frequent in Spain and is increasing in incidence.
Therefore, it would be desirable to improve the oversight and surveillance of this condition.
Due to the fact that strongyloidiasis can be fatal, we believe that there is a need to establish
risk categories for inclusion in national guidelines/protocols for screening individuals at risk
of developing strongyloidiasis.
URI
DOI
https://doi.org/10.1371/journal.pone.0189449
Aparece en las colecciones